← FDA Drug Approvals (Drugs@FDA)

EMPAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2021-01-28

Drug application

FDA Application #

ANDA212365

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMPAGLIFLOZIN

Generic name

Empagliflozin

Active ingredients

EMPAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

ANNORA PHARMA

First approval

2021-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown